^
    Back
    Association details:
    Biomarker:PIGF-L
    Cancer:Glioblastoma
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    New
    Source:
    Clin Cancer Res
    Title:

    Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept

    Excerpt:
    Low levels of PlGF at baseline were associated with response (OR=0.15, 95% CI 0.02 to 0.97, p=0.046)…
    DOI:
    10.1158/1078-0432.CCR-11-0271
    Trial ID:
    NCT00369590